MedPath

Epinephrine

Generic Name
Epinephrine
Brand Names
Adrenalin, Allerject, Anapen, Articadent, Astracaine, Auvi-Q, Citanest, Citanest Forte, Emerade, Epipen, Lignospan, Marcaine, Marcaine With Epinephrine, Octocaine, Octocaine With Epinephrine, Orabloc, Scandonest, Sensorcaine, Sensorcaine With Epinephrine, Septanest, Septocaine, Symjepi, Ultacan, Ultracaine, Vivacaine, Xylocaine, Xylocaine With Epinephrine, Zorcaine, Eurneffy
Drug Type
Small Molecule
Chemical Formula
C9H13NO3
CAS Number
51-43-4
Unique Ingredient Identifier
YKH834O4BH
Background

Epinephrine, also known as adrenaline, is a hormone and neurotransmitter and produced by the adrenal glands that can also be used as a drug due to its various important functions. Though it has long been used in the treatment of hypersensitivity reactions, epinephrine in the auto-injector form (EpiPen) has been available since 1987 in the USA. Many new products/biosimilars and dosage routes have been approved under various names over the last several decades , , . On August 16, 2018, Teva Pharmaceuticals USA gained approval to market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths . Dosage delivery routes for epinephrine include intravenous, inhalation, nebulization, intramuscular injection, and subcutaneous injection.

In general, the most common uses of parenteral epinephrine are to relieve respiratory distress due to bronchospasm, to provide rapid relief of hypersensitivity (anaphylactic or anaphylactoid) reactions to drugs, animal serums and other allergens, and to prolong the action of infiltration anesthetics . In addition to the above functions, epinephrine is the primary drug administered during cardiopulmonary resuscitation (CPR) to reverse cardiac arrest , . It can be used in severe cases of croup .

Indication

Epinephrine injection is indicated in the emergency treatment of type I allergic reactions, including anaphylaxis. It is also used to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock.

Epinephrine's cardiac effects may be of use in restoring cardiac rhythm in cardiac arrest due to various causes but is not used in cardiac failure or in hemorrhagic, traumatic, or cardiogenic shock .

Epinephrine is used as a hemostatic agent. It is also used in treating mucosal congestion of hay fever, rhinitis, and acute sinusitis; to relieve bronchial asthmatic paroxysms; in syncope due to complete heart block or carotid sinus hypersensitivity; for symptomatic relief of serum sickness, urticaria, angioneurotic edema; for resuscitation in cardiac arrest following anesthetic accidents; in simple (open angle) glaucoma; for relaxation of uterine musculature and to inhibit uterine contractions. Epinephrine injection can be utilized to prolong the action of local anesthetics .

In addition to the above, epinephrine is used as an over the counter (OTC) agent for the intermittent symptoms of asthma, such as wheezing, tightness of chest and shortness of breath . It is also used for the maintenance of mydriasis during intraocular surgery .

Associated Conditions
Anaphylaxis, Angioneurotic Edema, Bleeding, Bronchospasm, Complete Heart Block, Hypotension, Idiopathic Anaphylaxis, Laryngotracheobronchitis, Mild Intermittent Asthma, Nasal Congestion, Open Angle Glaucoma (OAG), Respiratory Distress, Severe Asthma, Syncope, Type I Hypersensitivity, Urticaria, Uterine Contractions, Ventricular Fibrillation, Resuscitation in cardiac arrest following anesthetic accidents, Severe hypersensitivity reactions, Unresponsive Asystole, Unresponsive Bradycardia

Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation

Early Phase 1
Recruiting
Conditions
Obesity
Interventions
First Posted Date
2024-05-16
Last Posted Date
2024-12-05
Lead Sponsor
Mayo Clinic
Target Recruit Count
24
Registration Number
NCT06416969
Locations
🇺🇸

Mayo Clinic in Rochester, Rochester, Minnesota, United States

Immediate Post-Operative Anesthesia With Either Lidocaine or Bupivacaine

Early Phase 1
Completed
Conditions
Periodontal Diseases
Interventions
Other: Placebo
First Posted Date
2024-03-05
Last Posted Date
2024-03-08
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
72
Registration Number
NCT06293807
Locations
🇺🇸

The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

Liposomal Bupivacaine Use in Alveolar Bone Graft Patients

Phase 3
Recruiting
Conditions
Cleft Lip and Palate
Interventions
First Posted Date
2024-02-29
Last Posted Date
2024-07-03
Lead Sponsor
Kerry O'Rourke
Target Recruit Count
60
Registration Number
NCT06284434
Locations
🇺🇸

Shriners Children's Chicago, Chicago, Illinois, United States

Epinephrine in Irrigation Fluid for Visualization During Ankle Surgery

Phase 3
Withdrawn
Conditions
Intraoperative Bleeding
Interventions
Procedure: Normal Saline irrigation fluid
First Posted Date
2024-02-20
Last Posted Date
2024-10-14
Lead Sponsor
The Guthrie Clinic
Target Recruit Count
78
Registration Number
NCT06264596
Locations
🇺🇸

Robert Packer Hospital, Sayre, Pennsylvania, United States

Comparing the Efficiency of Two Approaches in Patients at Risk of Developing Intraoperative Floppy Iris Syndrome

Phase 4
Completed
Conditions
Intraoperative Floppy Iris Syndrome
Age-related Cataract
Adrenergic Receptor Antagonist Adverse Reaction
Cataract
Interventions
First Posted Date
2024-02-20
Last Posted Date
2024-02-20
Lead Sponsor
University Hospital Olomouc
Target Recruit Count
164
Registration Number
NCT06266962
Locations
🇨🇿

Department of Ophthalmology, University Hospital Olomouc, Olomouc, Czechia

Comparative Efficacy of Hypertonic Saline vs Adrenaline Nebulization in Acute Bronchiolitis

Phase 3
Recruiting
Conditions
Acute Bronchiolitis Due to Respiratory Syncytial Virus
Interventions
Drug: Hypertonic Saline Solution, 1 Ml
First Posted Date
2024-02-20
Last Posted Date
2024-08-22
Lead Sponsor
Combined Military Hospital, Pakistan
Target Recruit Count
60
Registration Number
NCT06267118
Locations
🇵🇰

Combined Military Hospital, Nowshera, KPK, Pakistan

Comparative Bioavailability of Intranasal Epinephrine

Phase 1
Completed
Conditions
Anaphylactic Reaction
Anaphylaxis
First Posted Date
2024-01-12
Last Posted Date
2024-03-21
Lead Sponsor
Nasus Pharma
Target Recruit Count
12
Registration Number
NCT06205134
Locations
🇮🇱

Clinical Pharmacology Unit, Hadassah Medical Center, Ein Karem, Jerusalem, Israel

Control of Iatrogenic Endobronchial Bleeding by Tranexamic Acid, Adrenalin and Hemagglutinase

Early Phase 1
Recruiting
Conditions
Iatrogenic Endobronchial Bleeding
Interventions
Drug: Tranexamic Acid;
Drug: Hemagglutinase
First Posted Date
2023-11-28
Last Posted Date
2023-11-28
Lead Sponsor
China-Japan Friendship Hospital
Target Recruit Count
300
Registration Number
NCT06149091
Locations
🇨🇳

China-Japan Friendship Hospital, BeiJing, Beijing, China

Prophylactic Tranexamic Acid Versus Adrenaline During Flexible Bronchoscopy

Not Applicable
Recruiting
Conditions
Bleeding
Hemoptysis
Interventions
First Posted Date
2023-11-24
Last Posted Date
2025-03-27
Lead Sponsor
Clinical Hospital Centre Zagreb
Target Recruit Count
840
Registration Number
NCT06145191
Locations
🇭🇷

University Hospital Centre Zagreb, Zagreb, Croatia

Epinephrine to Prevent Postintubation Collapse in Shocked ICU Patients

Not Applicable
Recruiting
Conditions
Shock
Interventions
Drug: isotonic fluid
First Posted Date
2023-11-03
Last Posted Date
2023-11-08
Lead Sponsor
Ain Shams University
Target Recruit Count
44
Registration Number
NCT06115473
Locations
🇪🇬

Ain Shams University Hospitals at Intensive care units department, Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath